Surgical versus non-surgical management of early stage oropharyngeal squamous cell carcinoma.
National guidelines state that early-stage oropharyngeal carcinoma can be treated by either primary surgery or radiotherapy. There is a paucity of evidence comparing surgery versus non-surgical therapy within the same population. With the shift in head and neck cancer treatment towards primary chemoradiation, the aim of this observational cohort study was to help define whether surgery still has a role for early-stage oropharyngeal disease, using a national prospective audit of all new head and neck cancers recruited between 1999 and 2001 in Scotland. Patients with T1-2 N0 M0 tumours were identified. Patients were divided into those treated surgically (±adjuvant radiotherapy) or non-surgically. Five-year outcome data were calculated. Forty-two patients were treated surgically (13 received adjuvant radiotherapy) and 32 patients treated non-surgically. Disease-specific 5-year survival was 69 and 60%, respectively (p = 0.22). Locoregional failure occurred in seven of the surgical group and five of the non-surgical group. The success of chemoradiotherapy and the evidence for its use as adjuvant therapy may dissuade clinicians from considering surgical intervention. This study demonstrates the outcomes of surgical and non-surgical therapy within the same population. Where clear margins can be achieved, and in the absence of negative prognostic neck pathology, surgery remains a good option; allowing radiotherapy to be preserved for locoregional failures or second primary tumours. Although there are limitations to this study, it does demonstrate the benefit of prospective population data collection.
O'Hara
James
J
Department of Otolaryngology Head and Neck Surgery, The Freeman Hospital, Newcastle upon Tyne, UK.
MacKenzie
Ken
K
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002294:Carcinoma, Squamous Cell / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D037981:Neck Dissection; D009367:Neoplasm Staging; D009959:Oropharyngeal Neoplasms / Q000453:epidemiology / Q000473:pathology / Q000628:therapy*; D010611:Pharyngectomy / Q000379:methods*; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D012606:Scotland / Q000453:epidemiology; D015996:Survival Rate
Am J Clin Oncol. 2006 Jun;29(3):290-7
16755183
Int J Radiat Oncol Biol Phys. 1996 Jan 15;34(2):289-96
8567328
Clin Otolaryngol Allied Sci. 2002 Dec;27(6):541-8
12472528
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):743-51
15183477
Laryngoscope. 2008 Dec;118(12):2129-34
18948826
Arch Otolaryngol Head Neck Surg. 2003 Jan;129(1):36-43
12525192
Laryngoscope. 2009 Mar;119(3):534-40
19235752
Laryngoscope. 2009 Nov;119(11):2156-64
19824067
Eur Arch Otorhinolaryngol. 2004 May;261(5):276-81
14551793
N Engl J Med. 2004 May 6;350(19):1937-44
15128893
Laryngoscope. 1998 Jul;108(7):1014-9
9665249
Head Neck. 2000 May;22(3):294-6
10748454
Laryngoscope. 2009 Mar;119(3):508-15
19235742
Laryngoscope. 2009 Feb;119(2):307-11
19172611